Thrombophilia Testing: from Genetic Predisposition to Discrimination

Andreas Verstraete^{1

2}, Kathleen Freson², Peter Verhamme^{1

2}, Thomas Vanassche^{1

2}

Affiliations

¹ Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium.
² Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium.

Andreas Verstraete et al. TH Open. 2024.

. 2024 Apr 8;8(2):e177-e180.

doi: 10.1055/a-2284-4285. eCollection 2024 Apr.

Andreas Verstraete^{1

2}, Kathleen Freson², Peter Verhamme^{1

2}, Thomas Vanassche^{1

2}

¹ Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium.
² Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium.

No abstract available

Conflict of interest statement

Conflict of Interest None declared.

1. Naess I A, Christiansen S C, Romundstad P, Cannegieter S C, Rosendaal F R, Hammerstrøm J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5(04):692–699. - PubMed
1. Huang W, Goldberg R J, Anderson F A, Kiefe C I, Spencer F A. Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009) Am J Med. 2014;127(09):829–3.9E6. - PMC - PubMed
1. Khider L, Gendron N, Mauge L. Inherited thrombophilia in the era of direct oral anticoagulants. Int J Mol Sci. 2022;23(03):1821. - PMC - PubMed
1. Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet. 2003;362(9383):523–526. - PubMed
1. Christiansen S C, Cannegieter S C, Koster T, Vandenbroucke J P, Rosendaal F R. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA. 2005;293(19):2352–2361. - PubMed